Priorix
Measles, mumps, rubella combined vaccine (live, attenuated)
Product Details
WHO Product ID
FVP-P-61
Status
Prequalified
Date of prequalification
Vaccine type
Measles, mumps, rubella combined vaccine (live, attenuated)
Abbreviated Name
MMR
Commercial Name
Priorix
PQ Holder
Belgium
NRA of record
Federal Agency for Medicines and Health Products (FAMPH)
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Vial
Number of doses
1
Route of administration
Intramuscular or subcutaneous
Vaccine Vial Monitor
Type 7
Shelf-life
24 months
Storage temperature
2 - 8°C
Diluent
Water for injection
Preservative
None
Multidose Vial Policy
Not applicable
Remarks
Diluent can be stored at +25°C.
Product Packaging
Secondary Container
Tertiary Container
Component Packed
Active (Vaccine)
Total doses
100
Description
Carton of 100 vials (active) [Dimensions 17.8 x 14.7 x 3.7 cm]
Dimensions
17.8 x 14.7 x 3.7 cm
Cold Chain Volume (cm³/dose)
9.68
Component Packed
Diluent
Total doses
100
Description
Carton of 100 ampoules (diluent) [Dimensions 19 x 18 x 7.5 cm]
Dimensions
19.0 x 18.0 x 7.5 cm
Cold Chain Volume (cm³/dose)
25.65
